CERTIFIED HEALTH IT PRODUCT LIST (CHPL) PRODUCT NUMBER: 15.04.04.3138.IMAT.08.00.0.221230
DEVELOPER REAL WORLD TESTING PLAN PAGE URL: https://imatsolutions.com/index.php/ecqm/real-world-testing/
IMAT Solutions is a certified Data Aggregator Vendor, therefore, the scope of the Real World Testing will focus on the QRDAs created based on data received by IMAT Solutions from certified EHRs that support providers/clinicians that have an interface to IMAT Solutions. IMAT’s eCQM measures currently support over 80 clinicians, that will extend to over 1,000 clinicians by the end of 2024, and several high volume MCOs (Managed Care Organizations). These clinicians and MCOs participate in the CMS Quality Payment Program (QPP), HEDIS Reporting and CMS eCQM reporting. Additionally, the data within IMAT Solutions also support extracts and Quality Dashboards for MCOs, providers and specific State Quality Dashboards.
IMAT Solutions receives data via QRDA1s, CCDs, proprietary flat files etc. and then calculates eCQM measure results, produces any needed submission files (ex: QRDA III), publishes results to performance dashboards, and provides detailed analysis on customers’ submission readiness (gaps in care, data formatting issues, etc.)
IMATs objective with these quality and regulatory reporting products is to ensure 100% successful submission on behalf of our customers. IMATs C3 technology allows IMAT to transmit certified data to customers throughout the reporting year. Customers can also login, to run quality measures on demand for any specified time period, to view measure results on-demand. IMAT also provides year round, white-glove service to identify and address any data issues negatively impacting performance results or submission.
IMAT V8 – 15.04.04.3138.IMAT.08.00.0.221230 supports the following standards for 170.315(c2);(c3)
2024 CMS QRDA I Implementation Guide for Hospital Quality Reporting (170.205(h)(3))
• Method used for standard update: SVAP
• Date notification sent to ONC-ACB: December 15th, 2022
• Date notification sent to customers: July 12th, 2023
• Measure used to demonstrate: Cypress with Drummond supervision
2024 CMS QRDA III Implementation Guide for Eligible Clinicians (170.205(k)(3))
• Method used for standard update: SVAP
• Date notification sent to ONC-ACB: December 15th, 2022
• Date notification sent to customers: July 12th, 2023
• Measure used to demonstrate: Cypress with Drummond supervision
Description of Measurement
Count of patient that IMAT has received QRDA I records or other clinical data for that were represented in the generated QRDA III records.
Associated Certification Criteria
Modules: 170.315(c)(2),(c)(3)
Justification for Selected Measurement
Shows IMATs ability to generate QRDA III records for use in submissions to CMS and TJC
Care Setting
IMAT has received certification through NCQA as Validated Data Stream under their Data Aggregator Validation (DAV) program. IMAT V8 will focus on care settings which have been validated under the DAV program. These currently include the Outpatient Care and Outpatient Lab care settings.
Expected Outcomes
Success of this product relies on the ability to generate QRDA III records that can be reported to CMS and TJC, so any amount greater than 0 will be deemed to be a success. From this total benchmarks will be established for future years to ensure that the product continues to grow and provide more data for CMS and TJC
Description of Measurement
Companion measure used to track the percentage of QRDA III’s generated that were submitted to CMS and TJC. This will be used to track quality issues that could affect reporting.
Associated Certification Criteria
Modules: 170.315(c)(2),(c)(3)
Justification for Selected Measurement
Tracks the quality of data submitted to CMS and TJC
Care Setting
IMAT has received certification through NCQA as Validated Data Stream under their Data Aggregator Validation(DAV) program. IMAT V8 will focus on care settings which have been validated under the DAV program this currently includes the Outpatient Care and Outpatient Lab care settings.
Expected Outcomes
IMAT targets 100% of all QRDA IIIs generated will be submitted, however the target will be adjusted in subsequent validations to reflect real world outcomes based on actual data.
Description of Measurement
Companion measure used to track the stability of the product across each eCQM measure. The success of the product relies on the ability to produce useful data that can be submitted to CMS and TJC
Associated Certification Criteria
Modules: 170.315(c)(2),(c)(3)
Justification for Selected Measurement
Tracks the quality of the product submitting data to CMS and TJC
Care Setting
IMAT has received certification through NCQA as Validated Data Stream under their Data Aggregator Validation (DAV) program. IMAT V8 will focus on care settings which have been validated under the DAV program. These currently include the Outpatient Care and Outpatient Lab care settings.
Expected Outcomes
IMAT targets 0 issues per measure. New targets will be created on subsequent validations based on issues that have been found and their target dates for resolution.
January 1st, 2024 – Patient data which belongs to a Care settings covered by the DAV program will be used to calculate data for the eCQM measure which we are certified on and QRDA III’s will be created. Data will be collected from this point to be used in the Real World Testing measures communicated in this document.
December 31st, 2024 – IMAT will collect and gather all generated data for each respective measure in the Real World Testing plan, and compile results and outcomes from the test plan.
This Real-World Testing plan is complete with all required elements, including measures that address all certification criteria and care settings. All information in this plan is up to date and fully addresses the health IT developer’s Real World Testing requirements.
Authorized Rep Name: Ken Barbe
Authorized Rep Email: ken.barbe@imatsolutions.com
Authorized Rep Phone: 905.975.4666
Date: Nov 1, 2023
Authorized Rep Signature:
